m+Medelevator.RU
← Поиск публикаций
Children (Basel, Switzerland) · 2025

Outcomes of DISE-Directed Surgery for Obstructive Sleep Apnoea in Children.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Blokland Rachel, Friedland Yael, Kalra Aryan, Withers Adelaide, Vijayasekaran Shyan

Аннотация

Background: Obstructive sleep apnoea (OSA) affects 1-4% of children and may cause significant health issues if left untreated. While adenotonsillectomy is the primary intervention, up to 33% of children experience residual OSA. Drug-induced sleep endoscopy (DISE) enables identification of the site of anatomical obstruction, thus facilitating targeted surgical interventions. The approach of the institution at which this research was conducted is to only perform DISE in selected patients including those who fail adenotonsillectomy or when adenotonsillectomy is not expected to be successful. Methods: This retrospective case series reviewed 19 children who underwent DISE and DISE-directed surgeries for OSA at Perth Children's Hospital between 2018 and 2021. Polysomnography (PSG) parameters pre- and post-surgery were compared. Results: Overall, there were no significant improvements in PSG parameters in the group post-surgery. However, improvements were found with sub-group analyses in younger children, those with severe pre-operative OSA and non-obese children. No significant improvement was observed in children with Trisomy 21. Revision adenoidectomy was the most frequently performed surgery and tongue-base reduction achieved the highest rate of improvement (80%) based on PSG parameters. Conclusions: DISE-directed surgery offers a promising approach for managing residual paediatric OSA. Outcomes may be favourable in younger patients, those with severe OSA, and non-obese patients. Further research with larger cohorts is warranted to refine surgical strategies.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты